TTC Oncology TTC-352-101 Metastatic Breast Cancer Study Skip To Content

Study ID: TTC Oncology TTC-352-101 Metastatic Breast Cancer Study

Title:

Phase 1 Study of TTC-352 in Patients with Metastatic Breast Cancer Progressing on Endocrine Therapy

Location:
Sioux Falls Region
Principal Investigator:
Jonathan Bleeker, MD
Disease:
Breast - Invasive
Stage:
Phase I
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.